Brief: Moleculin Biotech Inc - To Unblind Miracle Trial Data Before June 30, 2026 - SEC Filing
13/05/2026 13:12
May 13 (Reuters) - Moleculin Biotech Inc MBRX.O: MOLECULIN BIOTECH INC - TO UNBLIND MIRACLE TRIAL DATA BEFORE JUNE 30, 2026 - SEC FILING MOLECULIN BIOTECH INC - MIRACLE TRIAL ON TRACK TO COMPLETE PART A RECRUITMENT IN Q3 2026 - SEC FILING Further company coverage: MBRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Moleculin Biotech
See all newsMoleculin Biotech Q1 net loss widens as R&D costs rise
Brief: Moleculin Biotech Inc - To Unblind Miracle Trial Data Before June 30, 2026 - SEC Filing
Brief: Moleculin Miracle Trial Delivers 40% Preliminary Blinded CRc Rate (N=30)
U.S. STOCKS ON THE MOVE-Albemarle, Lowe's, nLIGHT
Moleculin Biotech rises as cancer drug shows no heart damage in trials